Truxima

Cephalon, Inc.🇺🇸 United States

FDA Page

Effective Date: Jul 13, 2026
Approval ID: 9af3ddc7-4217-417a-ac89-8704edc5bc44
Products: 2 registered
Version: 16

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TRUXIMA safely and effectively. See full prescribing information for TRUXIMA. TRUXIMA (rituximab-abbs) injection, for intravenous use Initial U.S. Approval: 2018 TRUXIMA (rituximab-abbs) is biosimilar to RITUXAN (rituximab).

Quick Stats

Total Products2

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.